Pharmaceutical Preparations · DE · CIK 899460
Develops and commercializes patient-centric therapies for cardiometabolic and orphan lung diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 10, 2026: 1 insider bought $259K · 2 sold $946K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Castagna MichaelChief Executive Officer | Buy | 100,000 | $2.59 | $259K |
| Jan 8, 2026 | Tross Stuart AChief People & Workpl Officer | Sell | 47,006 | $6.33 | $298K |
| Dec 17, 2025 | Castagna MichaelChief Executive Officer | Sell | 65,804 | $6.01 | $395K |
| Dec 16, 2025 | Castagna MichaelChief Executive Officer | Sell | 21,310 | $6.00 | $128K |
| Dec 12, 2025 | Castagna MichaelChief Executive Officer | Sell | 20,806 | $6.00 | $125K |
| Dec 2, 2025 | Thomson DavidEVP Genl Counsel & Secretary | Sell | 147,780 | $5.57 | $823K |
| Dec 2, 2025 | Castagna MichaelChief Executive Officer | Sell | 107,920 | $5.57 | $601K |
| Nov 14, 2025 | Singh Sanjay REVP Technical Operations | Sell | 18,777 | $5.03 | $94K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.